Head to Head Comparison of Upper Airway Stimulation and Continuous Positive Airway Pressure; a Pilot Study.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Thomas Jefferson University
- Enrollment
- 50
- Locations
- 2
- Primary Endpoint
- Difference in polysomnography (PSG) data between UAS and CPAP groups
Study Overview
Brief Summary
To date, there has been no head to head comparison of Upper Airway Stimulation (UAS) and Continuous Positive Airway Pressure (CPAP) utilizing a full night polysomnographic evaluation. With this study we aim to evaluate a pilot cohort of patients with OSA treated with CPAP or UAS using the WatchPAT polysomnography system.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 22 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age greater than 22 years old
- •History of moderate to severe OSA (AHI 15-65)
- •UAS implantation with postoperative titration and demonstrated successful use of therapy or has demonstrated the ability to tolerate CPAP for greater than 4 hours per night 5 days per week.
Exclusion Criteria
- Not provided
Arms & Interventions
Upper airway stimulation
Continuous positive airway pressure
Outcomes
Primary Outcomes
Difference in polysomnography (PSG) data between UAS and CPAP groups
Time Frame: 2 years
Difference in Functional Outcomes of Sleep questionnaire data between UAS and CPAP groups
Time Frame: 2 years
Difference in Epworth Sleepiness Scale questionnaire data between UAS and CPAP groups
Time Frame: 2 years
Secondary Outcomes
No secondary outcomes reported
